Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Antioxidant and Neuroprotective Potential of the Brown Seaweed Bifurcaria bifurcata in an in vitro Parkinson's Disease Model.

Joana Silva | Celso Alves | Rafaela Freitas | Alice Martins | Susete Pinteus | Joana Ribeiro | Helena Gaspar | Amparo Alfonso | Rui Pedrosa
Marine drugs | 2019

Bifurcaria bifurcata is a marine brown seaweed mainly found on the Atlantic coast. Herein, we report the antioxidant and neuroprotective activities of seven fractions (F1⁻F7) obtained by normal phase chromatography from the B. bifurcata dichloromethane extract, as well as of its two major isolated diterpenes. Total phenolic content of fractions was determined by the Folin⁻Ciocalteu method, while antioxidant activity was evaluated by the DPPH, ORAC, and FRAP assays. Neuroprotective effects were evaluated in a neurotoxic model induced by 6-hydroxydopamine (6-OHDA) in a human neuroblastoma cell line (SH-SY5Y), while the mechanisms associated to neuroprotection were investigated by the determination of mitochondrial membrane potential, H₂O₂ production, Caspase-3 activity, and by observation of DNA fragmentation. Fractions F4 and F5 exhibited the best neuroprotective and antioxidant activities, respectively. F4 fraction prevented changes in mitochondrial potential, and induced a reduction of H₂O₂ levels production and an increase in cell viability, suggesting that it may contain multi-target compounds acting on different pathways. Hence, this fraction was subjected to purification steps, affording the known diterpenes eleganolone and eleganonal. Both compounds exhibited antioxidant potential, being interesting candidates for further neuroprotective studies.

Pubmed ID: 30717087

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: UID/MAR/04292/2013
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: UID/Multi/04046/2013
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: PTDC/MAR-BIO/6149/2014
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: SAICTPAC/0019/2015
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: PTDC/BIA-OUT/29250/2017
  • Agency: Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund,
    Id: Centro-01-0145-FEDER-000018
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: SFRH/BD/103255/2014
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: SFRH/BD/97764/2013
  • Agency: Fundação para a Ciência e a Tecnologia,
    Id: SFRH/BD/96203/2013

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SH-SY5Y (tool)

RRID:CVCL_0019

Cell line SH-SY5Y is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SH-SY5Y (tool)

RRID:CVCL_0019

Cell line SH-SY5Y is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions